Challenge No 2: Missing industry hubs

The Asia Pacific region, barring the developed nations of Australia and Singapore, needs "critical mass" where interdepe...

May 17, 2012 | Thursday | Analysis
Aussies to get breast cancer treatment analysis

Singapore: Australian women will potentially have greater access to the only genomic test validated to predict whether p...

January 7, 2014 | Tuesday | News
Cancer Therapeutics reveals new targeted drug

Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...

July 5, 2012 | Thursday | News
Australia approves Hospira's biosimilar

Singapore: Hospira's Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered...

August 20, 2015 | Thursday | News
Trial of cancer killing virus-based drug is a success

Singapore: Viralytics Biotech and Amgen, released top line results on its oncolytic virotherapy investigational product...

March 22, 2013 | Friday | News
F&S: Double-digit growth for APAC pharma

Singapore: The pharmaceuticals industry in the Asia Pacific is thriving on the back of escalating population and increa...

December 5, 2012 | Wednesday | News
BSA-CMR Survey: APAC CROs stick to an average of 50 clients

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...

September 18, 2013 | Wednesday | Analysis
Phylogica, Janssen expand drug discovery tie-up

Singapore: Phylogica, a leading Australian peptide drug discovery company, is expanding its collaboration with Janssen B...

July 1, 2013 | Monday | News
New antibody-based drug to cure diabetes

Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and revers...

September 27, 2012 | Thursday | News
Hot investment destinations in Asia

Asia's two leading economies, India and China are actively working on new strategies to attract money into the bioscienc...

June 26, 2012 | Tuesday | Analysis
QrxPharma, Aesica expand drug delivery technology

Singapore: Australia-based QRxPharma has collaborated with Aesica Formulation Development for the world-wide promotion o...

July 22, 2013 | Monday | News
New medtech market infographic published

Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting arti...

June 10, 2013 | Monday | News
3M, Aussie firm collaborate to develop vaccine technology

Singapore: Australia based Ascend Biopharmaceuticals has collaborated with 3M Drug Delivery Systems to evaluate 3M's Tol...

November 29, 2013 | Friday | News
Fovia to image cancer cells using HD volume

Singapore: Fovia Medical, a world leader in volume rendering technology, and Contrast Imaging, a leading Australian pro...

April 1, 2013 | Monday | News
BioDiem, Griffith University join hands for antimicrobial compound

Singapore: Australian infectious disease therapy development company BioDiem signed an agreement with Griffith Universi...

November 9, 2012 | Friday | News
pSivida enrols first patient in Uveitis trial

Singapore: pSivida, a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye di...

July 3, 2012 | Tuesday | News
Australian CRO expands its operations in HongKong

Singapore: Australia-based contract research organization, Novotech, recently announced that it has expanded its Hong Ko...

January 23, 2015 | Friday | News
Cochlear electrode gets US FDA approval

Singapore: Cochlear has received the US Food & Drug Administration (FDA) approval for its Nucleus CI422 with Slim St...

June 13, 2012 | Wednesday | Regulatory